Concepedia

Publication | Open Access

Safety of Sacubitril/Valsartan Initiated During Hospitalization: Data from a Non-Selected Cohort

DOIFull Paper Access

26

Citations

12

References

2019

Year

Juan Carlos López‐Azor, Lourdes Vicent, María Jesús Valero‐Masa, Alberto Esteban‐Fernández, Manuel Gómez‐Bueno, Ángel Pérez, Pablo Díez‐Villanueva, Javier de Juan Bagudá, Ángel Manuel‐Iniesta, Ramón Bover,
ESC Heart Failure

Abstract

It is safe to initiate sacubitril/valsartan during hospitalization in daily clinical practice. Inpatients have a higher risk profile and receive low starting doses more frequently than outpatients.

References

YearCitations

Page 1